Bank of America Sees Upside in McKesson (MCK) Biosimilar Push, Raises Target to $1,040.
Share this article
Corporate
Score 65
Bullish
Bank of America Sees Upside in McKesson (MCK) Biosimilar Push, Raises Target to $1,040
Mar 11, 2026 01:09 UTC
MCK, XLV, AMGN
Medium term
Related Articles
Score 65
Bullish
GE Vernova (GEV) Selected to Supply 17 Wind Turbines for Fortore Wind Farm in Italy
Mar 14, 18:31
Score 85
Bullish
Applied Materials (AMAT) Partners with Micron (MU), SK Hynix for Next-Gen Memory Development
Mar 14, 18:31
Score 65
Bullish
Vertiv Holdings (VRT), Generate Capital Partner to Launch BYOP&C Ecosystem for Data Centers
Mar 14, 18:30
Score 35
Carpenter Technology (CRS) Announces Brian Malloy to Succeed Tony Thene as CEO
Mar 14, 18:30
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.